SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-10-183614
Filing Date
2010-08-09
Accepted
2010-08-09 17:27:20
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.htm S-3 209736
2 OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP dex51.htm EX-5.1 26954
3 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 21281
4 CONSENT OF MARCUM LLP dex231.htm EX-23.1 2324
5 GRAPHIC g47263g13w03.jpg GRAPHIC 8924
6 GRAPHIC g47263g25x07.jpg GRAPHIC 21039
7 GRAPHIC g47263g60r98.jpg GRAPHIC 26151
  Complete submission text file 0001193125-10-183614.txt   339769
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-168693 | Film No.: 101002670
SIC: 2836 Biological Products, (No Diagnostic Substances)